share_log

Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday

Benzinga Real-time News ·  Dec 19, 2022 21:31
  • Morgan Stanley cut VTEX (NYSE:VTEX) price target from $7 to $5. Â Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. VTEX shares fell 4.9% to close at $3.52 on Friday.
  • Keybanc cut Progyny, Inc. (NASDAQ:PGNY) price target from $55 to $45. Keybanc analyst Scott Schoenhaus maintained an Overweight rating on the stock. Progyny gained 4.1% to close at $31.83 on Friday.
  • SVB Leerink raised the price target on Roivant Sciences Ltd. (NASDAQ:ROIV) from $8 to $10. SVB Leerink analyst David Risinger maintained an Outperform rating on the stock. Roivant Sciences shares gained 1.1% to close at $7.32 on Friday.
  • Raymond James boosted W. P. Carey Inc. (NYSE:WPC) price target from $80 to $85. Raymond James analyst RJ Milligan maintained an Outperform rating on the stock. W. P. Carey shares fell 0.1% to $79.73 in pre-market trading.
  • Needham raised AtriCure, Inc. (NASDAQ:ATRC) price target from $55 to $58.. Needham analyst Mike Matson maintained a Buy rating on the stock. AtriCure shares fell 2.6% to close at $41.37 on Friday.
  • JP Morgan cut Glaukos Corporation (NYSE:GKOS) price target from $48 to $42. JP Morgan analyst Allen Gong upgraded the stock from Underweight to Neutral. Glaukos shares rose 0.8% to $42.83 in pre-market trading.
  • Jefferies raised Moderna, Inc. (NASDAQ:MRNA) price target from $170 to $275. Jefferies analyst Michael Yee upgraded the stock from Hold to Buy. Moderna shares fell 6.7% to close at $193.29 on Friday.
  • Stifel boosted Xylem Inc. (NYSE:XYL) price target from $113 to $115. 170. Stifel analyst Nathan Jones downgraded the stock from Buy to Hold. Xylem shares fell 0.6% to $109.27 in pre-market trading.
  • Piper Sandler raised ConocoPhillips (NYSE:COP) price target from $155 to $157. Piper Sandler analyst Ryan Todd maintained an Overweight rating on the stock. ConocoPhillips shares rose 1% to $111.50 in pre-market trading.
  • HC Wainwright & Co. boosted Astria Therapeutics, Inc. (NASDAQ:ATXS) price target from $13 to $20. HC Wainwright & Co. analyst Joseph Pantginis maintained the stock with a Buy rating. Astria Therapeutics shares jumped 4.8% to close at $11.81 on Friday.
  • Baird cut L3Harris Technologies, Inc. (NYSE:LHX) price target from $290 to $241. Baird analyst Peter Arment downgraded the stock from Outperform to Neutral. L3Harris Technologies shares fell 1.5% to $210.00 in pre-market trading.

Check out this: 4 Penny Stocks Insiders Are Buying: Getaround, Corvus Pharmaceuticals And More

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment